Cintas Corporation (CTAS) Stock Price & Analysis
Cintas Corporation (CTAS) closed at USD 224.04 on Thursday, October 22, 2026, up 1.77% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 220.15; the Oct 22, 2026 session ranged USD 221.31–225.43 on volume of 2,263,095 shares. Market capitalization is $88.96B, with a 52-week range of USD 161.16–225.43 (NMS). Source: Nexqual, retrieved October 23, 2026 at 09:26 UTC.
Also available as compact Markdown for AI agents: nexqual.com/CTAS.md
Key facts (CTAS)
- Last four reported quarters (through Aug 31, 2026): revenue $11.6B, net income $2.06B (17.8% margin), free cash flow $2.03B (SEC filings).
- Valuation: P/E 43.2x (avg 43.6x at the last 3 fiscal year-ends), EV/EBITDA 28.4x, net debt $2.19B.
- 3 of 80 tracked superinvestors hold CTAS (13F, Q2 2026): 1 new, 1 added, 0 reduced, 1 unchanged.
- Analysts: Buy (mean 2.45 on a 1–5 scale) (20 analysts), mean target USD 218.31 (range 181–250).
- Total return with dividends: 1Y +17.6% vs S&P 500 +14.9%; 5Y +120.0% vs S&P 500 +80.3%.
- Next earnings: 2026-12-17, EPS estimate USD 1.36, revenue estimate $3.03B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (CTAS)
| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $7.85B | $8.82B | $9.60B | $10.3B | $11.3B | $11.6B |
| Gross profit | $3.63B | $4.17B | $4.69B | $5.17B | $5.71B | — |
| Operating income | $1.59B | $1.80B | $2.07B | $2.36B | $2.61B | $2.70B |
| Net income | $1.24B | $1.35B | $1.57B | $1.81B | $2.00B | $2.06B |
| EPS (diluted) | $2.91 | $3.25 | $3.79 | $4.40 | $4.91 | — |
| Free cash flow | $1.30B | $1.26B | $1.66B | $1.76B | $1.88B | $2.03B |
| Gross margin | 46.2% | 47.3% | 48.8% | 50.0% | 50.7% | — |
| Operating margin | 20.2% | 20.4% | 21.6% | 22.8% | 23.1% | 23.4% |
| Net margin | 15.7% | 15.3% | 16.4% | 17.5% | 17.8% | 17.8% |
| Revenue growth | +10.4% | +12.2% | +8.9% | +7.7% | +8.9% | — |
| Cash + short-term investments | $90.5M | $124M | $342M | $264M | $289M | — |
| Total debt | $2.80B | $2.49B | $2.48B | $2.42B | $2.43B | — |
Fiscal years end May. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Aug 31, 2026) (CTAS)
P/E 43.2x · P/S 7.7x · EV/EBITDA 28.4x · EV/Sales 7.9x · P/FCF 43.7x · P/B 17.1x · FCF yield 2.29% · Earnings yield 2.32% · Dividend yield (paid, TTM) 0.81% · Buyback yield (TTM) 1.13% · Net debt $2.19B · EV $91.1B
P/E at fiscal year-ends: May 2026 34.8x, May 2025 51.3x, May 2024 44.6x.
Superinvestors (SEC 13F-HR, Q2 2026) (CTAS)
3 of 80 tracked investors hold CTAS. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Jensen Investment Management | 1.38% | $56.7M | New position | |
| Mairs & Power | Mairs & Power Funds | 0.04% | $4.6M | Added +21.5% |
| Dodge & Cox Funds | Dodge & Cox | <0.01% | $306K | Unchanged |
Analysts (CTAS)
Consensus Buy (mean 2.45 on a 1–5 scale), 20 analysts; mean target USD 218.31 (low 181, high 250).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-30 | Citigroup | Target raised | Sell | $180 → $181 |
| 2026-09-29 | Argus Research | Target raised | Buy | $230 → $240 |
| 2026-09-24 | UBS | Target raised | Buy | $230 → $235 |
| 2026-09-24 | Baird | Target raised | Outperform | $214 → $222 |
| 2026-09-24 | Truist Securities | Target raised | Buy | $225 → $230 |
| 2026-09-24 | RBC Capital | Reiterated | Sector Perform | $206 |
| 2026-09-22 | Citigroup | Target raised | Sell | $175 → $180 |
| 2026-07-17 | Argus Research | Target raised | Buy | $220 → $230 |
| 2026-07-16 | UBS | Target raised | Buy | $228 → $230 |
| 2026-07-16 | Wells Fargo | Target raised | Overweight | $245 → $250 |
| 2026-07-16 | RBC Capital | Reiterated | Sector Perform | $206 |
| 2026-07-16 | Baird | Target raised | Outperform | $200 → $214 |
Total return (dividends reinvested) (CTAS)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +17.6% | +120.0% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +17.7% | +17.0% |
| Volatility (annualized) | 23.2% | 23.8% |
| Max drawdown | -20.0% (Mar 2026→May 2026) | -26.7% (Jun 2025→Mar 2026) |
CTAS analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Nov 2026) | $1.36 | $1.36 | +0.1% | $3.03B | 14 |
| Next quarter (ends Feb 2027) | $1.34 | $1.37 | -1.9% | $3.03B | 14 |
| Current fiscal year (ends May 2027) | $5.54 | $5.43 | +2.0% | $12.25B | 18 |
| Next fiscal year (ends May 2028) | $6.16 | $6.05 | +1.8% | $13.17B | 18 |
Key Statistics (as of October 23, 2026 at 09:26 UTC)
| Price | USD 224.04 |
|---|---|
| Change | ▲ 1.77% (up) |
| Previous Close | USD 220.15 |
| Open | USD 222.23 |
| Day Range | USD 221.31 – 225.43 |
| 52-Week Range | USD 161.16 – 225.43 |
| Volume | 2,263,095 shares |
| Market Cap | $88.96B |
| Exchange | NMS |
Technical Analysis (CTAS)
Nexqual's technical model rates CTAS "BUY" based on 5 bullish and 3 bearish signals across 127 daily candles, as of October 23, 2026 at 09:26 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 78.56 (overbought) |
| vs SMA50 | Above (USD 202.23) |
| MACD | 5.42 (positive) |
Analyst Ratings (CTAS)
Wall Street analysts rate CTAS "Buy" based on 20 analysts, with a mean price target of USD 218.31 (range USD 181–250), per Nexqual as of October 23, 2026 at 09:26 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 20 |
| Mean Target | USD 218.31 |
| High Target | USD 250 |
| Low Target | USD 181 |
| Buy / Hold / Sell | 10 / 9 / 1 |
Earnings (CTAS)
| Next Earnings Date | 2026-12-17 |
|---|---|
| EPS Estimate | USD 1.36 |
| Revenue Estimate | $3.03B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-08-31 | USD 1.39 vs est 1.35 ▲ beat |
| 2026-05-31 | USD 1.29 vs est 1.24 ▲ beat |
| 2026-02-28 | USD 1.24 vs est 1.24 ▲ beat |
| 2025-11-30 | USD 1.21 vs est 1.2 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Financials & Fundamentals (CTAS)
| Total Revenue | $11.56B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +10.90% |
| Gross Margin | +50.99% |
| Operating Margin | +24.10% |
| Profit Margin | +17.82% |
| ROE | +41.38% |
| Debt / Equity | 0.52 |
| Current Ratio | 1.45 |
| Total Cash | $364.58M |
| Total Debt | $2.71B |
| Free Cash Flow (last four quarters to Aug 2026, SEC 10-Q / 10-K) | $2.03B (17.6% of revenue) |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Financial Health Score (CTAS)
Nexqual rates Cintas Corporation's overall financial health "Solid" across five dimensions, as of October 23, 2026 at 09:26 UTC.
| Growth | Solid — Revenue +9% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 51%, operating 24% (last 12 months) |
| Balance Sheet | Solid — $244M cash and investments vs $2.43B debt (Aug 2026, SEC) |
| Cash Flow | Strong — FCF $2.03B (last 4 quarters to Aug 2026, SEC), 18% margin |
| Efficiency | Strong — ROE 41%, ROA 16.7% |
Ownership (CTAS)
| Insider Ownership | +14.55% |
|---|---|
| Institutional Ownership | +70.21% |
| Shares Outstanding | 397.08M |
| Float | 339.07M |
| Short % of Float | +4.22% |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Leadership (CTAS)
Cintas Corporation is led by Todd M. Schneider, CEO & Director, per Nexqual as of October 23, 2026 at 09:26 UTC.
| CEO & Director | Todd M. Schneider |
|---|---|
| Executive Chairman | Scott D. Farmer |
| President & COO | James N. Rozakis |
| Executive VP & CFO | Scott A. Garula |
| Senior Vice President of Human Resources | Max Langenkamp |
Major Backers & Investors (CTAS)
Notable institutional backers of Cintas Corporation include Invesco, Fidelity, FMR, LLC, according to Nexqual as of October 23, 2026 at 09:26 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Invesco | 3.42% |
| Fidelity | 1.69% |
| FMR, LLC | 1.59% |
| Price (T.Rowe) Associates Inc | 1.45% |
| Goldman Sachs | 1.18% |
| NORGES BANK | 1.1% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 8.98% |
| BlackRock | 6.69% |
| State Street | 3.98% |
| Geode Capital | 2.4% |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RELX | RELX PLC PLC | USD 40.62 | ▲ 3.81% |
| TRI | Thomson Reuters Corp | USD 123.26 | ▲ 6.94% |
| CPRT | Copart, Inc. | USD 29.09 | ▲ 5.44% |
| GPN | Global Payments Inc. | USD 85.88 | ▲ 2.81% |
| RBA | RB Global, Inc. | USD 84.39 | ▲ 2.91% |
| ULS | UL Solutions Inc. | USD 73.63 | ▼ 0.88% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:26 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt